spacer_alt
spacer_alt
Referrals Clinical Trials Department Newsletter Additional Links
spacer_alt
spacer_alt
 Home
 Patient Care
 Neurosurgery Research
  (BTRC) Brain Tumor Research Center
  Aghi Laboratory
  Alvarez-Buylla Laboratory
  Bankiewicz Laboratory
  Berger Laboratory
  Bergers Laboratory
  Cha Laboratory
  Clinical Neuro-Oncology Research
  Costello Laboratory
  Gupta Laboratory
  Haas-Kogan Laboratory
  Hodgson Laboratory
  Kunwar Laboratory
  Lal Laboratory
  Parsa Laboratory
  Pieper Laboratory
  Weiss Laboratory
  Wiencke Laboratory
  Wrensch Epidemiology Group
  Program Project Grant
  SPORE Grant Projects
  PBTF Grant Projects
  PLGA Grant Projects
  (BASIC) Brain and Spinal Injury Center
  Cerebrovascular Research
  Epilepsy Research
  Movement Disorders Research
  Pain Research
  Pediatric Clinical Research
  Tissue Bank
  Research Core Facility
  Guidelines on Research Data and Reports
 Academics/Residency
 Faculty/Staff
 General Information
 Administrative Resources
Brain Tumor Research Center
spacer_alt
Home > Neurosurgery Research > BTRC
spacer_alt
 
Brain Tumor Research Center
Our mission is to find a cure
 
Continuously funded by grants from the National Institutes of Health (NIH) since 1972, the Brain Tumor Research Center (BTRC) at UCSF is internationally recognized as a major research and treatment center for adults and children with tumors of the brain and spinal cord. The basic science laboratories of the BTRC and the Michael Douglas Pediatric BTRC, in collaboration with the Brain Tumor Center's Clinical Neuro-Oncology Program, emphasize translational research into the biology and behavior of brain tumors - research in which scientists and health care clinicians work in partnership to translate laboratory findings into new or improved forms of clinical therapy. Many BTRC researchers are also members of UCSF's Comprehensive Cancer Center, a designated National Cancer Institute (NCI) research center.
 
Multi-laboratory studies:
 
Specialized Program of Research Excellence (SPORE): The BTRC is one of four institutions to have received a SPORE grant for the study of brain tumors by the NCI. SPORE grants are intended to foster interaction between basic and applied scientists, providing them with the flexibility to rapidly test new approaches to the prevention and treatment of cancer.
 
Program Project Grant: The BTRC has been funded by a program project grant for 32 years. In 2007, BTRC investigators took this program in a new direction by incorporating studies of convection enhanced delivery into the the program's overall focus on neuroimaging.
 
Pediatric Brain Tumor Foundation Pre-Institute Award :
In 2006, the Pediatric Brain Tumor Foundation (PBTF) awarded the BTRC a grant to central nervous system tumors in children. The grant funds five research projects that focus on pediatric brainstem glioma and medulloblastoma.
 
Pediatric Low Grade Astrocytoma Foundation Award: Investigators in the BTRC have been given a research award by the nonprofit Pediatric Low Grade Astrocytoma Foundation to study stem cells in pediatric fibrillary astrocytoma.
 
More about the BTRC...
 
Manish Aghi MD, PhD
Oncolytic viral therapies; vascular biology of glioma
 
Arturo Alvarez-Buylla PhD
Developmental neuroscience; stem-cell neurobiology
 
Krys Bankiewicz MD, PhD
Convection drug-delivery systems; gene therapy
 
Mitchel Berger MD
Brain mapping; molecular genetic basis, biology, and therapy of brain tumors
 
Gabriele Bergers PhD
Angiogenesis; tumor invasion
 
Soonmee Cha PhD
Perfusion magnetic resonance imaging
 
Joe Costello PhD
Functional genomics
 
Nalin Gupta MD, PhD
Pediatric brain tumors; cell-cell interactions
 
Daphne Haas-Kogan MD
Apoptosis and genetic mutations; therapeutic irradiation enhancement
 
Graeme Hodgson PhD
Characterization of genes that contribute to the cancer phenotype
 
C. David James PhD
Molecular biology of CNS cancer; Analysis of mutant epidermal growth factor receptors in malignant gliomas; Rodent model testing of experimental therapies
 
Sandeep Kunwar MD
Immunotoxins by convection-enhanced delivery; pituitary tumors
 
Anita Lal PhD
Biology of meningiomas
 
Katherine Lamborn PhD
Biostatistics
 
Andrew Parsa MD, PhD
Immunotherapy
 
Russ Pieper PhD
Signal transduction, models of human gliomagenesis and drug resistance
 
William Weiss MD, PhD
Mouse models of human brain tumors
 
John K. Wiencke PhD
Epidemiological and clinical studies in neuroepidemiology
 
Margaret Wrensch PhD
Epidemiology and biostatistics
 
BTRC Associates
 
James Barkovich MD
Pediatric neuroradiology
 
Andrew W. Bollen DVM, MD
Neuropathology
 
William P. Dillon Jr. MD
Neuroradiology, magnetic source imaging and functional magnetic resonance imaging
 
Joe W. Gray PhD
UCSF Cancer Center, cancer genetics
 
Randall A. Hawkins MD
Radiology, neural imaging
 
Frank McCormick PhD
Director, UCSF Cancer Center, signal transduction, gene therapy
 
Tracy McKnight PhD
Magnetic resonance spectroscopy
 
Sarah J. Nelson PhD
Magnetic resonance spectroscopy
 
John Park MD
Immunoliposomes
 
Patricia (Penny) K. Sneed MD
Radiation oncology, hyperthermia
 
David Stokoe PhD
Molecular genetics
 
Daniel B. Vigneron PhD
Magnetic resonance spectroscopy
 
William M. Wara MD
Pediatric radiation neuro-oncology
 
Brain Tumor Research Center
Department of Neurological Surgery
University of California, San Francisco
Research Offices
1855 Folsom Street, Suite 535
Box 1631
San Francisco, California 94143-1631
tel 415-353-3915; fax 415-353-3907
 
Attn: Elizabeth Garrity — Chief Administrative Officer
garritye@neurosurg.ucsf.edu
 
Click Here for Clinical Trial Information
 
UCSF UCSF Medical Center UCSF School of Medicine
spacer_alt
spacer_alt
spacer_alt